Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura
PHASE1CompletedINTERVENTIONAL
Timeline
Start Date
October 31, 1999
Conditions
Esophageal CancerLung CancerMalignant MesotheliomaMetastatic Cancer
Interventions
DRUG
decitabine
Trial Locations (2)
20892
Center for Cancer Research, Bethesda
20892-1182
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00019825 - Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura | Biotech Hunter | Biotech Hunter